Parini Michael 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Parini Michael
EVP & CLO
Transactions
- Sale
Common Stock
2021-02-05$215.00/sh−1,930$414,950→ 57,227 total - Exercise/Conversion
Common Stock
2021-02-05$86.52/sh+1,930$166,984→ 59,157 total - Exercise/Conversion
Common Stock
2021-02-05−1,930→ 0 totalExercise: $86.52Exp: 2027-02-02→ Common Stock (1,930 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- [F2]Fully vested.